NEWS 82 FEED & ADDITIVE MAGAZINE February 2023 CHS Inc. and Cargill, two of the U.S.’s leading agribusinesses, announced the intent to expand the scope of their joint venture, TEMCO LLC, by adding the Cargill-owned export grain terminal in Houston, Texas. The addition of the Houston terminal will expand the joint venture’s export capabilities, providing shipping access for grains, oilseeds and byproducts through the port of Houston. TEMCO currently operates three facilities in the Pacific Northwest: Portland, Ore.; Kalama, Wash.; and Tacoma, Wash. These three facilities distribute grain to global markets, primarily located in the Asia-Pacific region. Through TEMCO, both companies look forward to building on 24 years of successful partnership to expand global grain market access for U.S. farmers to help meet the increasing global need for food. “We’re pleased to continue to build upon our successful relationship with Cargill to expand the reach of TEMCO,” said John Griffith, executive vice president of ag business for CHS. “In keeping with our purpose of creating connections to empower agriculture, access to the Houston terminal provides additional options for area cooperatives and farmers to participate in the global marketplace, helping to advance CHS growth strategy for the region and open new opportunities for U.S. farmers.” The Houston terminal is located approximately 40 miles inland from the Gulf of Mexico via Galveston Bay. With six million bushels of storage and capacity for 350 rail cars, the facility handles up to 250 million bushels annually. The terminal receives both trucks and railcars with a variety of commodities for global export. Read more>> CHS and Cargill to expand TEMCO operations Professor Charles Hofacre, President of the Southern Poultry Research Group (SPRG) presented results of a trial at the 2023 International Poultry Scientific Forum in Georgia, USA. The work, titled “Prevention and control of necrotic enteritis with an essential oil (Orego-Stim) and an organic acid (pHorce)”, reported that Orego-Stim and pHorce supplementation was effective in managing broilers and supporting performance through a necrotic enteritis challenge window. “Necrotic enteritis is commonly seen in broilers from 14-28 days and is caused by over-population of Clostridium perfringens, with coccidia infection acting as a predisposing factor,” explained Professor Hofacre. “The most common form of necrotic enteritis is subclinical, which can lead to negative effects on growth rate and feed efficiency due to intestinal damage and impairment of nutrient absorption”. In the trial, 1800 Ross x Ross chicks were randomly assigned to 1 of 4 groups (Challenge control, Orego-Stim: 1000 g/t, Orego-Stim: 500 g/t and Orego-Stim + pHorce: 300 g/t + 500 g/t). On day 0, all groups received a live coccidia vaccine, and on day 14 were challenged with Clostridium perfringens via the drinking water. Mortality, feed intake and FCR were recorded until 42 days of age. Broilers fed diets supplemented with Orego-Stim and pHorce had a significantly lower mortality as a result of necrotic enteritis infection, lower overall mortality and improved feed intakes. Orego-Stim supplementation resulted in a numerically improved FCR compared to the group of NE challenged broilers in the control group. Read more>> New research reveals effects of Orego-Stim and pHorce supplementation in broilers
RkJQdWJsaXNoZXIy MTUxNjkxNQ==